Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-25-000129
Filing Date
2025-08-11
Accepted
2025-08-11 07:29:53
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20250630.htm   iXBRL 10-Q 650196
2 EX-10.2 exhibit102-20250630xemploy.htm EX-10.2 113157
3 EX-10.4 exhibit104-20250630xemploy.htm EX-10.4 100791
4 EX-10.5 exhibit105-cappedvalueappr.htm EX-10.5 67623
5 EX-31.1 exhibit311-20250630q1.htm EX-31.1 9618
6 EX-31.2 exhibit312-2025630q1.htm EX-31.2 9581
7 EX-32.1 exhibit321-2025630q1.htm EX-32.1 4454
8 EX-32.2 exhibit322-2025630q1.htm EX-32.2 4455
  Complete submission text file 0001764013-25-000129.txt   4452154

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20250630.xsd EX-101.SCH 30789
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20250630_cal.xml EX-101.CAL 40884
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20250630_def.xml EX-101.DEF 157385
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20250630_lab.xml EX-101.LAB 468747
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20250630_pre.xml EX-101.PRE 320740
64 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20250630_htm.xml XML 375520
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 251200178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)